- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Equine Rabies Immunoglobulin (ERIG) will have significant change from previous year. By the most conservative estimates of global Equine Rabies Immunoglobulin (ERIG) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Equine Rabies Immunoglobulin (ERIG) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Rabies Immunoglobulin (ERIG) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Equine Rabies Immunoglobulin (ERIG), covering the supply chain analysis, impact assessment to the Equine Rabies Immunoglobulin (ERIG) market size growth rate in several scenarios, and the measures to be undertaken by Equine Rabies Immunoglobulin (ERIG) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
1500IU
1000IU
400IU
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Category II Exposure
Category III Exposure
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Serum China
Lanzhou Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Wuhan Institute of Biological Products
Bharat Serums
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Equine Rabies Immunoglobulin (ERIG) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Equine Rabies Immunoglobulin (ERIG) market by identifying its various subsegments.
Focuses on the key global Equine Rabies Immunoglobulin (ERIG) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Equine Rabies Immunoglobulin (ERIG) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Equine Rabies Immunoglobulin (ERIG) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Equine Rabies Immunoglobulin (ERIG)?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Equine Rabies Immunoglobulin (ERIG) Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Consumption 2015-2025
2.1.2 Equine Rabies Immunoglobulin (ERIG) Consumption CAGR by Region
2.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
2.2.1 1500IU
2.2.2 1000IU
2.2.3 400IU
2.2.4 Other
2.3 Equine Rabies Immunoglobulin (ERIG) Consumption by Type
2.3.1 Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
2.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2015-2020)
2.4 Equine Rabies Immunoglobulin (ERIG) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Equine Rabies Immunoglobulin (ERIG) Consumption by Application
2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Value and Market Share by Type (2015-2020)
2.5.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2015-2020)
3 Global Equine Rabies Immunoglobulin (ERIG) by Company
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2018-2020)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2018-2020)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2018-2020)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2018-2020)
3.3 Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company
3.4 Global Equine Rabies Immunoglobulin (ERIG) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Equine Rabies Immunoglobulin (ERIG) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Equine Rabies Immunoglobulin (ERIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Equine Rabies Immunoglobulin (ERIG) by Regions
4.1 Equine Rabies Immunoglobulin (ERIG) by Regions
4.2 Americas Equine Rabies Immunoglobulin (ERIG) Consumption Growth
4.3 APAC Equine Rabies Immunoglobulin (ERIG) Consumption Growth
4.4 Europe Equine Rabies Immunoglobulin (ERIG) Consumption Growth
4.5 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Growth
5 Americas
5.1 Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Countries
5.1.1 Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020)
5.1.2 Americas Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020)
5.2 Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Type
5.3 Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Regions
6.1.1 APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Regions (2015-2020)
6.1.2 APAC Equine Rabies Immunoglobulin (ERIG) Value by Regions (2015-2020)
6.2 APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Type
6.3 APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Equine Rabies Immunoglobulin (ERIG) by Countries
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Type
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) by Countries
8.1.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020)
8.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Type
8.3 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Equine Rabies Immunoglobulin (ERIG) Distributors
10.3 Equine Rabies Immunoglobulin (ERIG) Customer
11 Global Equine Rabies Immunoglobulin (ERIG) Market Forecast
11.1 Global Equine Rabies Immunoglobulin (ERIG) Consumption Forecast (2021-2025)
11.2 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Regions
11.2.1 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Regions (2021-2025)
11.2.2 Global Equine Rabies Immunoglobulin (ERIG) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Type
11.8 Global Equine Rabies Immunoglobulin (ERIG) Forecast by Application
12 Key Players Analysis
12.1 Serum China
12.1.1 Company Information
12.1.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Serum China Latest Developments
12.2 Lanzhou Institute of Biological Products
12.2.1 Company Information
12.2.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lanzhou Institute of Biological Products Latest Developments
12.3 Premium Serums
12.3.1 Company Information
12.3.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.3.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Premium Serums Latest Developments
12.4 Haffkine Bio-Pharmaceutical
12.4.1 Company Information
12.4.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.4.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Haffkine Bio-Pharmaceutical Latest Developments
12.5 Wuhan Institute of Biological Products
12.5.1 Company Information
12.5.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.5.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Wuhan Institute of Biological Products Latest Developments
12.6 Bharat Serums
12.6.1 Company Information
12.6.2 Equine Rabies Immunoglobulin (ERIG) Product Offered
12.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bharat Serums Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Equine Rabies Immunoglobulin (ERIG) Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Equine Rabies Immunoglobulin (ERIG) Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Equine Rabies Immunoglobulin (ERIG) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of 1500IU
Table 7. Major Players of 1000IU
Table 8. Major Players of 400IU
Table 9. Major Players of Other
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2015-2020) ($ million)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Value by Application (2015-2020)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Application (2015-2020)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Application (2015-2020)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Sales by Company (2017-2019) (K Units)
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company (2017-2019)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company (2017-2019)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company (2017-2019)
Table 25. Global Equine Rabies Immunoglobulin (ERIG) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Equine Rabies Immunoglobulin (ERIG) Products Offered
Table 27. Equine Rabies Immunoglobulin (ERIG) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Consumption by Regions 2015-2020 (K Units)
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Regions 2015-2020
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Value by Regions 2015-2020 ($ Millions)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Regions 2015-2020
Table 32. Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries (2015-2020)
Table 34. Americas Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries (2015-2020)
Table 36. Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Type (2015-2020) (K Units)
Table 37. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Table 38. Americas Equine Rabies Immunoglobulin (ERIG) Consumption by Application (2015-2020) (K Units)
Table 39. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Table 40. APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries (2015-2020)
Table 42. APAC Equine Rabies Immunoglobulin (ERIG) Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Equine Rabies Immunoglobulin (ERIG) Value Market Share by Regions (2015-2020)
Table 44. APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Type (2015-2020) (K Units)
Table 45. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Table 46. APAC Equine Rabies Immunoglobulin (ERIG) Consumption by Application (2015-2020) (K Units)
Table 47. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Table 48. Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries (2015-2020)
Table 50. Europe Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries (2015-2020)
Table 52. Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Type (2015-2020) (K Units)
Table 53. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Table 54. Europe Equine Rabies Immunoglobulin (ERIG) Consumption by Application (2015-2020) (K Units)
Table 55. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Table 64. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 65. Equine Rabies Immunoglobulin (ERIG) Customer List
Table 66. Global Equine Rabies Immunoglobulin (ERIG) Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Forecast by Regions
Table 68. Global Equine Rabies Immunoglobulin (ERIG) Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share Forecast by Regions
Table 70. Global Equine Rabies Immunoglobulin (ERIG) Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Equine Rabies Immunoglobulin (ERIG) Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share Forecast by Type (2021-2025)
Table 74. Global Equine Rabies Immunoglobulin (ERIG) Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Equine Rabies Immunoglobulin (ERIG) Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share Forecast by Application (2021-2025)
Table 78. Serum China Product Offered
Table 79. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Serum China Main Business
Table 81. Serum China Latest Developments
Table 82. Serum China Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 83. Lanzhou Institute of Biological Products Product Offered
Table 84. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Lanzhou Institute of Biological Products Main Business
Table 86. Lanzhou Institute of Biological Products Latest Developments
Table 87. Lanzhou Institute of Biological Products Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 88. Premium Serums Product Offered
Table 89. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Premium Serums Main Business
Table 91. Premium Serums Latest Developments
Table 92. Premium Serums Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 93. Haffkine Bio-Pharmaceutical Product Offered
Table 94. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Haffkine Bio-Pharmaceutical Main Business
Table 96. Haffkine Bio-Pharmaceutical Latest Developments
Table 97. Haffkine Bio-Pharmaceutical Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 98. Wuhan Institute of Biological Products Product Offered
Table 99. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Wuhan Institute of Biological Products Main Business
Table 101. Wuhan Institute of Biological Products Latest Developments
Table 102. Wuhan Institute of Biological Products Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bharat Serums Product Offered
Table 104. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. Bharat Serums Main Business
Table 106. Bharat Serums Latest Developments
Table 107. Bharat Serums Basic Information, Company Total Revenue (in $ million), Equine Rabies Immunoglobulin (ERIG) Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Equine Rabies Immunoglobulin (ERIG) Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Equine Rabies Immunoglobulin (ERIG) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 1500IU
Figure 7. Product Picture of 1000IU
Figure 8. Product Picture of 400IU
Figure 9. Product Picture of Other
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type (2015-2020)
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Type (2015-2020)
Figure 12. Equine Rabies Immunoglobulin (ERIG) Consumed in Category II Exposure
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Market: Category II Exposure (2015-2020) (K Units)
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Market: Category II Exposure (2015-2020) ($ Millions)
Figure 15. Equine Rabies Immunoglobulin (ERIG) Consumed in Category III Exposure
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Market: Category III Exposure (2015-2020) (K Units)
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Market: Category III Exposure (2015-2020) ($ Millions)
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application (2015-2020)
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Application (2015-2020)
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company in 2017
Figure 21. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Company in 2019
Figure 22. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company in 2017
Figure 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Company in 2019
Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Sale Price by Company in 2019
Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Regions 2015-2020
Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Value Market Share by Regions 2015-2020
Figure 27. Americas Equine Rabies Immunoglobulin (ERIG) Consumption 2015-2020 (K Units)
Figure 28. Americas Equine Rabies Immunoglobulin (ERIG) Value 2015-2020 ($ Millions)
Figure 29. APAC Equine Rabies Immunoglobulin (ERIG) Consumption 2015-2020 (K Units)
Figure 30. APAC Equine Rabies Immunoglobulin (ERIG) Value 2015-2020 ($ Millions)
Figure 31. Europe Equine Rabies Immunoglobulin (ERIG) Consumption 2015-2020 (K Units)
Figure 32. Europe Equine Rabies Immunoglobulin (ERIG) Value 2015-2020 ($ Millions)
Figure 33. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption 2015-2020 (K Units)
Figure 34. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value 2015-2020 ($ Millions)
Figure 35. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries in 2019
Figure 36. Americas Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries in 2019
Figure 37. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type in 2019
Figure 38. Americas Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application in 2019
Figure 39. United States Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 40. United States Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 41. Canada Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 42. Canada Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 43. Mexico Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 44. Mexico Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 45. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries in 2019
Figure 46. APAC Equine Rabies Immunoglobulin (ERIG) Value Market Share by Regions in 2019
Figure 47. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type in 2019
Figure 48. APAC Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application in 2019
Figure 49. China Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 50. China Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 51. Japan Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 52. Japan Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 53. Korea Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 54. Korea Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 55. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 56. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 57. India Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 58. India Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 59. Australia Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 60. Australia Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 61. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries in 2019
Figure 62. Europe Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries in 2019
Figure 63. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type in 2019
Figure 64. Europe Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application in 2019
Figure 65. Germany Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 66. Germany Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 67. France Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 68. France Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 69. UK Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 70. UK Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 71. Italy Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 72. Italy Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 73. Russia Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 74. Russia Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application in 2019
Figure 79. Egypt Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 80. Egypt Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 82. South Africa Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 84. Israel Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 86. Turkey Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Equine Rabies Immunoglobulin (ERIG) Consumption Growth 2015-2020 (K Units)
Figure 88. GCC Countries Equine Rabies Immunoglobulin (ERIG) Value Growth 2015-2020 ($ Millions)
Figure 89. Global Equine Rabies Immunoglobulin (ERIG) Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 90. Global Equine Rabies Immunoglobulin (ERIG) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 92. Americas Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 93. APAC Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 94. APAC Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 95. Europe Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 96. Europe Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 98. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 99. United States Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 100. United States Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 101. Canada Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 102. Canada Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 103. Mexico Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 104. Mexico Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 105. Brazil Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 106. Brazil Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 107. China Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 108. China Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 109. Japan Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 110. Japan Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 111. Korea Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 112. Korea Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 114. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 115. India Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 116. India Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 117. Australia Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 118. Australia Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 119. Germany Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 120. Germany Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 121. France Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 122. France Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 123. UK Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 124. UK Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 125. Italy Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 126. Italy Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 127. Russia Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 128. Russia Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 129. Spain Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 130. Spain Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 131. Egypt Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 132. Egypt Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 133. South Africa Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 134. South Africa Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 135. Israel Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 136. Israel Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 137. Turkey Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 138. Turkey Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Equine Rabies Immunoglobulin (ERIG) Consumption 2021-2025 (K Units)
Figure 140. GCC Countries Equine Rabies Immunoglobulin (ERIG) Value 2021-2025 ($ Millions)
Figure 141. Serum China Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Figure 142. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Figure 143. Premium Serums Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Figure 144. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Figure 145. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Figure 146. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
